減重研究日報

2026年9月22日(星期二)

本日收錄 29 篇文獻

⭐ 今日精選

📚 所有文獻

📄

Review of the Impact of Weight Loss and Body Mass Index in Clinical Trials of Nintedanib in Interstitial Lung Disease.

Review of the Impact of Weight Loss and Body Mass Index in Clinical Trials of Nintedanib in Interstitial Lung Disease.

INTRODUCTION: Weight loss and malnutrition are poor prognostic factors in patients with idiopathic p

📄

Application of Machine Learning to Predict 1-Year Weight Loss Outcomes After Laparoscopic Sleeve Gastrectomy.

Application of Machine Learning to Predict 1-Year Weight Loss Outcomes After Laparoscopic Sleeve Gastrectomy.

BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) is an effective treatment for obesity. This study

📄

Role of Oxytocin in Obesity.

Role of Oxytocin in Obesity.

PURPOSE OF REVIEW: This review will summarize the role of the hormone, oxytocin (OT), in the control

📄

Quantitative Insights into Tirzepatide and Semaglutide Using Longitudinal Systems Modeling.

Quantitative Insights into Tirzepatide and Semaglutide Using Longitudinal Systems Modeling.

CONTEXT: In a 28-week clinical trial of patients with type 2 diabetes (T2D), tirzepatide 15 m

📄

Association of Metabolic Score for Insulin Resistance with Intraoperative QTc Interval Changes During Laparoscopic Sleeve Gastrectomy: A Prospective Observational Study.

Association of Metabolic Score for Insulin Resistance with Intraoperative QTc Interval Changes During Laparoscopic Sleeve Gastrectomy: A Prospective Observational Study.

BACKGROUND: Preoperative metabolic status may influence cardiac repolarization under anesthesia. Thi

📄

Comparative effects of ketogenic diets and mediterranean diets on obesity and metabolic outcomes: a systematic review and meta-analysis.

Comparative effects of ketogenic diets and mediterranean diets on obesity and metabolic outcomes: a systematic review and meta-analysis.

Ketogenic diets (KD) and Mediterranean diets (MD) are among the most widely studied dietary approach

📄

Glucomannan and resistant starch in obesity management: a systematic review of satiety, gut fermentation, and weight-related and metabolic outcomes.

Glucomannan and resistant starch in obesity management: a systematic review of satiety, gut fermentation, and weight-related and metabolic outcomes.

Obesity is a growing global health challenge associated with dysregulated appetite, impaired gut fun

📄

Varying In-Person Coaching: Effects on Weight and Urinary Incontinence in Women with Obesity in a 20-Week Randomized Controlled Trial.

Varying In-Person Coaching: Effects on Weight and Urinary Incontinence in Women with Obesity in a 20-Week Randomized Controlled Trial.

INTRODUCTION AND HYPOTHESIS: Urinary incontinence (UI) affects 25-45% of women and is more common in

📄

Dissection of Obesity-Induced Spermatogenic Dysfunction at Single-Cell Resolution.

Dissection of Obesity-Induced Spermatogenic Dysfunction at Single-Cell Resolution.

BACKGROUND: Obesity is a major risk factor for male infertility; however, how different obesity etio

📄

Periodontitis Is Associated With Higher Blood Pressure and Pulse Wave Velocity in Late Adolescence: A Population-Based Study.

Periodontitis Is Associated With Higher Blood Pressure and Pulse Wave Velocity in Late Adolescence: A Population-Based Study.

OBJECTIVE: We hypothesized that periodontal tissue disruption and vascular dysfunction may coexist i

📄

Type 1 diabetes and cardiovascular medicine.

Type 1 diabetes and cardiovascular medicine.

There are an estimated 9.5 million people living with type 1 diabetes (T1D) globally, with cardiovas

📄

Hemoglobin Aand Weight Changes Associated With Grocery Delivery and Low-Carbohydrate Education in Adults With Type 2 Diabetes and Food Insecurity: Observational Quality Improvement Cohort Study.

Hemoglobin Aand Weight Changes Associated With Grocery Delivery and Low-Carbohydrate Education in Adults With Type 2 Diabetes and Food Insecurity: Observational Quality Improvement Cohort Study.

BACKGROUND: Type 2 diabetes mellitus (T2D) is one of the most significant chronic health challenges

📄

Modulation of circulating osteocalcin-expressing monocytes by glucagon like peptide-1 receptor agonists in type 2 diabetes: an exploratory pilot study.

Modulation of circulating osteocalcin-expressing monocytes by glucagon like peptide-1 receptor agonists in type 2 diabetes: an exploratory pilot study.

CONTEXT: The phenotypic drift of circulating monocytes toward osteoblast-like cells expressing osteo

📄

Therapy resistance-related ncRNAs in cervical cancer: biomarkers and therapeutic targets.

Therapy resistance-related ncRNAs in cervical cancer: biomarkers and therapeutic targets.

BACKGROUND: Cervical cancer remains a major cause of cancer-related morbidity and mortality, and res

📄

Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study.

Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study.

OBJECTIVE: We aimed to explore the heterogeneity of empagliflozin treatment effects on major adverse

📄

Heart failure with a preserved ejection fraction: synergy between cardiac and extracardiac mechanisms and effects of novel therapies.

Heart failure with a preserved ejection fraction: synergy between cardiac and extracardiac mechanisms and effects of novel therapies.

Heart failure with preserved ejection fraction (HFpEF) is a systemic disease in which metabolic como

📄

Agreement of Over-the-Counter Continuous Glucose Monitors With Capillary-Meter Glucose in Young Adults Without Diabetes.

Agreement of Over-the-Counter Continuous Glucose Monitors With Capillary-Meter Glucose in Young Adults Without Diabetes.

BACKGROUND: Over-the-counter continuous glucose monitors (OTC CGMs) are increasingly used by individ

📄

Preclinical and First-In-Human Evaluation of Ribupatide (HRS9531), a Dual GLP-1/GIP Receptor Agonist.

Preclinical and First-In-Human Evaluation of Ribupatide (HRS9531), a Dual GLP-1/GIP Receptor Agonist.

AIMS: This study assessed the preclinical and clinical pharmacokinetics (PK), pharmacodynamics (PD),

📄

Effect of Semaglutide on Thigh Skeletal Muscle Volume, Fat Infiltration and Physical Function in People With Obesity: Secondary Analysis of STEP UP.

Effect of Semaglutide on Thigh Skeletal Muscle Volume, Fat Infiltration and Physical Function in People With Obesity: Secondary Analysis of STEP UP.

AIMS: To assess the effect of semaglutide on body composition and physical function. MATERIALS AND M

📄

Economic evaluations of antiobesity medications: A systematic literature review.

Economic evaluations of antiobesity medications: A systematic literature review.

The global prevalence of obesity is rising rapidly. With several antiobesity medications approved an

📄

Cargo-aware design of dissolving microneedles: an FEA-guided rational framework reveals distinct delivery mechanisms for small and large molecules.

Cargo-aware design of dissolving microneedles: an FEA-guided rational framework reveals distinct delivery mechanisms for small and large molecules.

Transdermal delivery of glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (SE

📄

Patterns of Ultra-Processed Food Consumption and Their Associations With Body Composition in Primary School Children in Semarang City, Indonesia.

Patterns of Ultra-Processed Food Consumption and Their Associations With Body Composition in Primary School Children in Semarang City, Indonesia.

AIMS: This study aimed to examine the association between ultra-processed food (UPF) consumption and

📄

Sex and Socioeconomic Differences in the Initiation of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort Study.

Sex and Socioeconomic Differences in the Initiation of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort Study.

AIMS: Cardioprotective glucose-lowering drugs (GLDs) remain underutilised in individuals with Type 2

📄

Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study.

Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study.

AIMS: To evaluate the association between tirzepatide and recorded oral and periodontal outcomes com

📄

mTOR signaling in aging: from causality to geroprotective interventions and hallmark-level outcomes.

mTOR signaling in aging: from causality to geroprotective interventions and hallmark-level outcomes.

The mechanistic target of rapamycin (mTOR) pathway is an important integrator of processes involved

📄

Applicability of Non-Invasive Eligibility Criteria for MASH Pharmacotherapy: A Multicentre Cohort Study.

Applicability of Non-Invasive Eligibility Criteria for MASH Pharmacotherapy: A Multicentre Cohort Study.

BACKGROUND AND AIMS: Non-invasive tests (NITs) are increasingly used to guide patient selection for

📄

Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly. Diabetes Care 2026;49:XXXX-XXXX.

Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly. Diabetes Care 2026;49:XXXX-XXXX.

摘要 unavailable

📄

Response to Comment on Meier et al. Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study.

Response to Comment on Meier et al. Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study.

摘要 unavailable

📄

Comment on Meier et al. Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study.

Comment on Meier et al. Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study.

摘要 unavailable

📊 主題分布

減重研究
29

🏷️ 熱門關鍵字

weight lossobesity